Background/rationale: Various interventions are available to manage verbal agitation (VA), but our understanding regarding their acceptability is limited. The purpose of this study is to compare the acceptability of 3 interventions from the point of view of elderly individuals: direct interaction (DI), differential reinforcement of incompatible behaviors (DRI), and risperidone (RIS). Methods: Participants (N = 69) evaluated the acceptability of each treatment according to the description of a fictional person who demonstrated aggressive or nonaggressive VA. Results: There is an interaction between the type of intervention and the severity of VA. For nonaggressive VA, DI is the most acceptable intervention followed by DRI and RIS. For aggressive VA, DI and DRI are more acceptable than RIS, but there is not a significant difference between them. The acceptability of each intervention is not associated with the participants’ characteristics. Conclusion: The results of this study highlight the acceptability of DI for managing VA.
Cohen-Mansfield J.Agitation in the elderly: definitional and theoretical conceptualizations. Agitation in patients with dementia: a practical guide to diagnosis and management. Washington, DC: American Psychiatric Publishing, Inc; 2003 :1-22.
2.
Lai CKY.Vocally disruptive behaviors in people with cognitive impairment: Current Knowledge and future research directions. Am J Alz Dis. 1999;14(3):172-180.
3.
Shahar K., Snow AL, Souchek J., Ashton CM, Kunik MECut-off point of agitation. Clin Gerontol. 2003;21 (1-2):15-23.
4.
Draper B., Snowdon J., Meares S., et al. Case controlled study of nursing home residents referred for treatment of vocally disruptive behavior. Int Psychogeriatr . 2000;12(3):333-344.
5.
Bourque M., Voyer P.La gestion des symptômes psychologiques et comportementaux de la démence. Soins infirmiers aux aînés en perte d’autonomie . Québec: Édition du renouveau pédagogique Inc;2006:353-429.
6.
Sloane PD, Davidson S., Buckwalter K., et al. Management of the patient with disruptive vocalization. Gerontologist. 1997; 37(5):675-682.
7.
Landreville P. , Vézina J., Bédard A.Symptômes comportementaux de la démance: agitation verbale, comportements agressifs et errance. Symptômes comportementaux et psychologiques de la démence . Acton Vale, Québec, Canada: Edisem; 2005 .
8.
Patterson C. , Gauthier S., Bergman H., et al. The recognition, assessment and management of dementing disorders: conclusion of the canadian consensus conference on dementia. Can J of Neurol Sci.2001;28 (suppl 1):3-16.
9.
Herrmann N. , Gauthier S., Lysy PGClinical practice guidelines for severe Alzheimer’s disease. Alzheimers Dementia. 2007; 3(4):385-397.
10.
Hogan DB, Bailey A., Carwell A., et al. Management of mild to moderate Alzheimers disease and dementia . Alzheimers Dementia. 2007;3:355-384.
11.
Bourgeois MS , Burgio LD, Schulz R., Reach S., Palmer B.Modifying repetitive verbalizations of community-dwelling patients with AD . Gerontologist. 1997;37(1):30-39.
12.
Buchanan JA , Fisher JEFunctional assessment and noncontingent reinforcement in the treatment of disruptive vocalization in elderly dementia patients. J App Behav Anal. 2002;35: 99-103.
13.
Cariaga J., Burgio L., Flynn W., Martin D.A controlled study of disruptive vocalizations among geriatric residents in nursing homes. J Am Geriatr Soc. 1991;39:501-507.
14.
Cohen-Mansfield J., Werner P.Management of verbally disruptive behaviors in nursing home residents. J Gerontol Med Sci. 1997;56A(6):M369-M377.
15.
Doyle C., Zapparoni T., O’Connor D., Runci S.Efficacy of psychosocial treatments for noisemaking in severe dementia . Int Psychogeriatr.1997;9(4):405-422.
16.
McMinn B., Draper B.Vocally disruptive behaviour in dementia: development of an evidence based practice guideline. Aging Ment Health. 2005;9(1):16-24.
17.
Asp E., Cloutier F., Fay S., et al. Verbal repetition in patients with Alzheimer’s disease who receive donepezil. Int J Geriatr Psychiatry. 2006;21:426-431.
18.
Rockwood K. , Fay S., Jarrett P., Asp E.Effect of galantamine on verbal repetition on AD: a secondary analysis of the VISTA trial. Neurology . 2007;68: 1116-1121.
19.
Kopala LC, Honer WGThe use of Risperidone in severely demented patients with persistent vocalizations . Int J Geriatr Psychiatry. 1997;12:73-77.
20.
Barton S., Findlay D., Blake RAThe management of inappropriate vocalisation in dementia: a hierarchical approach . Int J of Geriatr Psychiatry. 2005 ;20:1180-1186.
21.
Kindermann SS, Dolder CR, Bailey A., Katz IR, Jeste DVPharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience. Drugs Aging. 2002 ;19:257-276.
22.
Frenchman IBRisperidone, haloperidol, and olanzapine for the treatment of behavioral disturbances in nursing home patients: A retrospective analysis. Curr Ther Res. 2000;61(10):742-750.
23.
Rabinowitz J., Katz IR, De Deyn PP, Brodaty H., Greenspan A., Davidson M.Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone. J Clin Psychiatry. 2004 ;65(10):1329-1334.
24.
Kazdin AEAcceptability of alternative treatments for deviant child behavior . J Appl Behav Anal. 1980;13(2): 259-273.
25.
Bravo G., Gagnon IM, Wildeman S., Marshall TD, Paquet M., Dubois M.-F. Comparison of Provincial and Territorial Legislation Governing Substitute Consent for Research. Can J Aging. 2005;24(3):237-249.
26.
Baltes MM, Lascomb SLCreating a healthy institutional environment for the elderly via behavior management. The nurse as a change agent. Int J of Nurs Stud.1975;12:5-12.
27.
Lundervold D., Lewin LMOlder adults’ acceptability of pharmacotherapy and behavior therapy for depression: Initial results. J Appl Gerontol. 1990;9(2):211-215.
28.
Burgio LD, Sinnott J., Janosky J., Hohman JMPhysicians’ acceptability of behavioral treatment and pharmacotherapy for behavioral disturbance in older adults. Gerontologist . 1992; 32(4):546-551.
29.
Burgio LD, Sinnott J.Behavioral treatments and pharmacotherapy: acceptability ratings by elderly individuals in residential settings. Gerontologist . 1990;30(6):811-816.
30.
Burgio LD, Sinnott J.Behavioral treatments and pharmacotherapy: acceptability ratings for elderly individuals. J Gerontol.1989;44(1):3-8.
31.
Algase DL, Beck C., Kolanowski A., et al. Need-driven dementia-compromised behavior: an alternative view of disruptive behavior. Am J Alzheimer’s Dis. 1996;11(1):0-19.
32.
Health Canada.Important safety information on atypical antipsychotic drugs and dementia. http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2005/atyp-antipsycho_hpc-cpseng.php . Accessed April 9, 2009.
33.
Burgio LD, Cotter EM, Stevens AB, Hardin JM, Sinnott J., Hohman JMElders’ acceptability ratings of behavioral treatments and pharmacotherapy for the management of geriatric behavioral disturbances. Gerontologist. 1995;35(5): 630-636.
34.
Falsetti AERisperidone for control of agitation in dementia patients. Am J Health-Syst Pharm. 2000;57(9):862-870.
35.
Burgio LD, Hardin JM, Sinnott J., Janosky J., Hohman JMNurses’ acceptability of behavioral treatments and pharmacotherapy for behavioral disturbances in older adults. Appl Nurs Res . 1995;8(4):174-181.
36.
Kunik ME, Walgama JP, Snow AL, et al. Documentation, assessment, and treatment of aggression in patients with newly dignosed dementia. Alz Dis AssocDisor. 2007;21(2): 115-121.
37.
Osterkamp L. , Mathews RM, Burgio LD, Hardin JMSocial workers’ acceptability ratings of behavioral treatments and pharmacotherapy for the management of geriatric behavior problems. Educ Gerontol. 1997;23(5):425-435.
